Introduction {#s001}
============

Leptospirosis, a disease caused by bacterial infection with various pathogenic serovars from genus *Leptospira*, occurs globally in numerous environments, typically associated with rural and agricultural populations (Vinetz [@B15]). However, infection can also occur among urban poor when large populations of synanthropic species serve as reservoirs (Vinetz et al. [@B16]). The disease, if recognized early, is treatable with antibiotics. However, the diverse range of signs and symptoms makes it challenging to diagnose. In addition, laboratory diagnostics are oftentimes unavailable at the level of community-based services. Diagnostic methods include PCR, which is common for early diagnosis of leptospirosis (Vinetz et al. [@B16]), and serological tests such as microscopic agglutination test (MAT) (Vinetz [@B15]).

In various regions of the world, leptospirosis does not require national mandatory reporting. For example, in Canada and the European Economic Area (EAA) countries, notification is not required (European Centre for Disease Prevention and Control [@B6]). In the United States, leptospirosis was reinstated as a nationally notifiable disease since January 2013 (Centers for Disease Control and Prevention (CDC) [@B4]). Ukraine has maintained active monitoring of the disease, recognizing that it remains an occupational disease for groups that contact animals that can serve as sources of the bacteria, as well as human populations that come into contact with synanthropic small mammals. As such, the information provides useful data on the temporal trends of disease in human populations at risk for spillover of zoonotic pathogens.

Materials and Methods {#s002}
=====================

Study area {#s003}
----------

The study is a summary of data about trends and changes in *Leptospira* infection during 11 years in Zakarpattia oblast, a region of Western Ukraine, where the disease is endemic. Zakarpattia oblast is located on the western boundary of Ukraine with Romania, Hungary, Poland, and Slovakia. The Carpathian Mountains cover almost two-thirds of the region, while the rest is lowlands. The region is predominantly (63%) rural, with more than half covered by forests, and the climate is moderately continental. Zakarpattia includes regions with foci for leptospirosis, the most commonly reported disease, as well as other zoonotic diseases, including hemorrhagic fevers and Lyme borreliosis.

Human data {#s004}
----------

Suspected human cases were identified at local health care facilities based on clinical signs and symptoms as well as histories of potential animal exposures. Sera from patients suspected of leptospirosis were collected throughout the oblast and tested at the Especially Dangerous Infections (EDIs) Laboratory of Zakarpattia Oblast Laboratory Center of the State Sanitary and Epidemiological Service (SSES) of Ukraine (currently named the Zakarpattia Oblast Laboratory Center of the Ministry of Health of Ukraine). This is the unique laboratory in the oblast authorized to perform these tests. Results were reported to the health care facilities; positive results were reported to SSES rayon (subterritorial) institutions for follow-up epidemiological investigation, and the Ministry of Health was notified.

Paired sera were screened initially at 1:5 and 1:50 dilutions. In case of positive reaction at these titers, we diluted the serum to 1:10, 1:100, 1:200, and less (the method is described in the Methodological Recommendations 9.1.1.098-02 Anti-Epidemic Measures and Laboratory Diagnostics of Leptospirosis approved by the Decree of the Chief State Sanitary Doctor of Ukraine No. 39 of 11 December 2002 \[Methodological Recommendations [@B10]\]). For negative control, we mixed physiological solution and *Leptospira* in equal volumes. Antibody titers of 1:100 were considered positives in combination with clinical and epidemiological data of the case. Fourfold increase of antibody titers in paired sera was a doubtless proof of an acute infection. MAT was performed against 13 *Leptospira* spp. serovars that were available in EDI Laboratory of Zakarpattia Oblast Laboratory Center of the SSES to identify the presumptive serogroup of infective serovar ([Table 1](#T1){ref-type="table"}).

###### 

Panel of Leptospira Reference Strains Used in the Microscopic Agglutination Test, According to the Respective Serovars and Serogroups (Methodological Recommendations 2002)

  *Nr.*   *Serogroup*                              *Serovar*                                         *Reference strain*
  ------- ---------------------------------------- ------------------------------------------------- -------------------------------------------------
  1       Icterohaemorrhagiae                      Copenhageni                                       M-20
  2       Grippotyphosa                            Grippotyphosa                                     Moskva V
  3       Pomona                                   Pomona                                            Pomona
  4       Canicola                                 Canicola                                          Hond-Utrecht IV
  5       Tarassovi                                Tarassovi                                         Perepelicin
  6       Hebdomadis                               Cabura                                            Cabura
  7       Sejroe^[a](#tf1){ref-type="table-fn"}^   Polonica wolffi^[a](#tf1){ref-type="table-fn"}^   493 Poland 3705^[a](#tf1){ref-type="table-fn"}^
  8       Javanica                                 Poi                                               Poi
  9       Autumnalis                               Autumnalis                                        Akijami A
  10      Australis                                Bratislava                                        Jez Bratislava
  11      Bataviae                                 Djatzi                                            HS-26
  12      Ballum                                   Ballum                                            Muz-127
  13      Pyrogenes                                Pyrogenes                                         Salinen
  14      Cynopteri                                Cynopteri                                         Vleermuis 3868

Serovar Polonica wolffi of Sejroe serogroup was not available in the diagnostic kit of *Leptospira* strains of Especially Dangerous Infection laboratory during the study period.

Mammal data {#s005}
-----------

Small mammals were collected as part of active case surveillance in follow-up to human cases as well as part of ongoing surveillance of wild animal sources of infection in areas that historically had been identified as leptospirosis foci near population centers. A diverse array of habitats (farmland, forest, shrubs, perennial grasses, and population centers) and landscapes and geographical zones of the oblast---mountain, foothill, and lowland---were surveyed.

Wild terrestrial mammals were collected with small snap traps used for "mouse-sized" mammals, while larger snap traps were used for "rat-sized" mammals. If animals were found alive in traps, to comply with bioethics requirements, euthanasia was performed according to national standards. Captured animals were transported to the EDI laboratory for testing to determine blood antibodies with MAT in the same way as it was described for human samples, except there was only a single sample from each animal. During rodent necropsy, we collected blood from heart cavity on filtration paper 1 × 1 cm, dried them out, and prepared "dry blood drops." We extracted the "dry blood drop" in 0.5 mL of physiological solution (dilution 1:10) to prepare next dilutions.

On average, 100--120 surveys by workers of the EDI laboratory bio group and SSES territorial institutions were organized annually. During a survey transect, 80--100 traps were set approximately every 5 meters. Traps were checked, animals collected, and the traps were reset one to two times, over night, per survey. Throughout a year, 1500--1800 trap-days were expended. Historically, epizootological surveys were conducted in each district ( = rayon) twice a year---in spring and during summer-autumn period (June--October). The size and number of traps in each biotope depended upon the size of the district and the species of mammals expected to be collected, and were determined by EDI laboratory biologist.

Statistical analysis of the data was performed using Excel software to calculate basic descriptive statistics and differences in rates.

Results {#s006}
=======

A total of 420 suspected cases of leptospirosis were identified by the health care surveillance system out of 2079 people presenting for evaluation (20.2%), and 401 of these (95.5%) were confirmed by MAT. Leptospirosis incidence fluctuated widely across years, but there was a general downward trend since the start of the study. Cases were more frequent during the first half of study (2005--2009) ranging from 36 to 51 cases, and peaked in 2010 (77 cases) before declining to 17--29 cases annually (2011--2015) (State Service of Ukraine for Emergency Situations (SSUES) [@B14]). The incidence ranged from 0.88 to 6.24 per 100 thousand, mirroring changes in the crude numbers. By comparison, the total annual numbers of cases in the entire country of Ukraine ranged from 301 to 679 cases, with an incidence of about one-third that of Zakarpattia oblast ([Table 2](#T2){ref-type="table"}). The temporal trend in the national incidence rate differed somewhat from that seen with Zakarpattia, with the highest numbers at the beginning of the study, but with a slower rate of decline in later years.

###### 

Annual Incidence of Leptospirosis in Zakarpattia Oblast (2005--2015) Compared with National Statistics

  *Years*        *No. of people diagnosed Ukraine*   *Morbidity per 100,000 people in Ukraine*   *No. of people with MAT-positive results/clinical dx of leptospirosis in Oblast*   *No. of people studied in Oblast*   *Rate per 100,000 population in Oblast*
  -------------- ----------------------------------- ------------------------------------------- ---------------------------------------------------------------------------------- ----------------------------------- -----------------------------------------
  2005           679                                 1.40                                        49/51                                                                              274                                 4.1
  2006           490                                 1.04                                        49/50                                                                              266                                 4.0
  2007           674                                 1.44                                        46/49                                                                              222                                 3.9
  2008           530                                 1.10                                        48/49                                                                              221                                 3.9
  2009           442                                 0.96                                        33/36                                                                              179                                 2.9
  2010           632                                 1.37                                        76/77                                                                              284                                 6.24
  2011           310                                 0.68                                        22/23                                                                              154                                 1.85
  2012           317                                 0.70                                        28/29                                                                              135                                 2.12
  2013           358                                 0.79                                        16/17                                                                              119                                 1.38
  2014           474                                 1.04                                        26/28                                                                              124                                 2.23
  2015           301                                 0.70                                        8/11                                                                               101                                 0.88
  Total number   5207                                Average rate 1.02                           401/420                                                                            2079                                Average rate 3.05

MAT, microscopic agglutination test.

The human case fatality rate (CFR) was evaluated in diagnosed patients throughout the study, with an average CFR of 12.5% in Zakarpattia. There was no overall trend in CFRs, with the lowest rates in 2009--2010. By comparison, the average national CFR was 9.8%, with less year-to-year variation ([Fig. 1](#f1){ref-type="fig"}).

![Case-fatality rates during the study period among patients with leptospirosis in Zakarpattia and nationally.](fig-1){#f1}

In most cases (70--100%), the patients showed evidence of infection with only one of six serogroups: Icterohaemorrhagiae, Hebdomadis, Pomona, or Canicola of *Leptospira interrogans*, Grippotyphosa of *Leptospira kirschneri*, or Tarassovi of *Leptospira borgpetersenii*. Other serogroups were identified only sporadically (2007 and 2013--2015). The dominant serogroup changed during monitoring. From 2005 to 2009, Icterohaemorrhagiae predominated among identified human cases. In 2010, this serogroup was abruptly displaced when 31 laboratory-confirmed cases of Grippotyphosa (from 76 cases) were identified. Grippotyphosa had not been previously reported in humans from the region, but it remained the predominant serogroup for 4 subsequent years. During the last 2 years of study, the diversity of serogroups increased with nearly equal occurrence of Tarassovi, Icterohaemorrhagiae and Pomona. During this time, several serogroups that had previously been rarely encountered (Autumnalis, Ballum, Javanica, and Cynopteri) became more commonly reported in humans (accounting for 26.5% of cases; [Fig. 2a](#f2){ref-type="fig"}).

![**(a)** Proportion of *Leptospira* serogroups in humans positive by MAT from 2005 to 2015. **(b)** Proportion of *Leptospira* serogroups in small mammals positive by MAT from 2005 to 2015. MAT, microscopic agglutination test.](fig-2){#f2}

Previous experience has shown that small mammals were leading sources of leptospirosis (Badra [@B2], Żmudzki et al. [@B19]). A total of 2820 small mammals were collected and tested by MAT ([Table 3](#T3){ref-type="table"}). The preponderance (84.5%) of individuals captured belonged to four species: *Apodemus agrarius*, *Rattus norvegicus*, *Mus musculus*, and *Apodemus sylvaticus*. The remaining six species (including the single individual of the European mole, *Talpa europaea*) were less commonly sampled.

###### 

Results of Epizootiological Study of Zakarpattia Oblast in 2005--2015

  *Species*   Apodemus agrarius   Rattus norvegicus   Apodemus flavicollis   Sorex araneus   Apodemus sylvaticus   Myodes glareolus   Microtus arvalis   Mus musculus   Dryomys nitedula   Talpa europaea                                                                                                                                                           
  ----------- ------------------- ------------------- ---------------------- --------------- --------------------- ------------------ ------------------ -------------- ------------------ ---------------- ---- -------------- ---- ----- -------------------- --- ---- ---------------- ---- ----- -------------- ---- ----- -------------- --- --- ----- --- --- -----
  2005        7                   89                  Pom.                   10              157                   Ict.               5                  27             Hebd.              0                7    ---            1    15    Ict.                 0   8    ---              4    68    Pom.           0    145   ---            0   0   ---   0   0   ---
  2006        17                  82                  Pom.                   25              145                   Ict.               0                  0              ---                0                0    ---            0    17    ---                  0   4    ---              6    32    Pom.           0    105   ---            0   0   ---   0   0   ---
  2007        15                  164                 Pom.                   10              126                   Ict.               2                  20             Gripp.             1                8    Pom.           3    36    Ict., Pom., Pyr.     1   9    Austr.           3    44    Pyr.           1    97    Ball.          0   0   ---   0   0   ---
  2008        4                   80                  Pom.                   4               86                    Ict.               0                  6              ---                0                18   ---            4    68    Pom., Gripp.         0   6    ---              0    9     ---            5    27    Ict.           0   0   ---   0   0   ---
  2009        11                  80                  Pom.                   15              54                    Ict.               0                  9              ---                1                13   Can.           0    34    ---                  0   0    ---              0    9     ---            2    47    Can., Gripp.   0   2   ---   0   0   ---
  2010        13                  69                  Pom.                   9               87                    Ict.               0                  9              ---                0                7    ---            0    38    ---                  0   0    ---              0    9     ---            5    42    Gripp.         0   0   ---   0   0   ---
  2011        14                  72                  Pom.                   4               34                    Gripp.             0                  30             ---                0                6    ---            3    12    Ict., Pom., Gripp.   1   5    Gripp.           0    6     ---            1    42    Gripp.         0   0   ---   0   1   ---
  2012        1                   7                   Gripp.                 3               10                    Pom.               0                  0              ---                0                0    ---            3    3     Pom.                 0   0    ---              0    6     ---            0    2     ---            0   0   ---   0   0   ---
  2013        0                   21                  ---                    1               10                    Gripp.             0                  0              ---                0                7    ---            3    14    Mixed (Pom.+Tar.)    0   0    ---              0    8     ---            0    46    ---            0   0   ---   0   0   ---
  2014        16                  31                  Gripp.                 0               4                     ---                4                  10             Gripp.             2                6    Can., Bat.     2    3     Gripp., Austr.       0   0    ---              2    7     Gripp., Bat.   8    10    Gripp.         0   0   ---   0   0   ---
  2015        6                   29                  Gripp.                 0               3                     ---                0                  6              ---                4                14   Gripp.         1    9     Gripp.               0   0    ---              0    0     ---            13   132   Gripp.         0   0   ---   0   0   ---
  Total       104                 724                 Pom.                   81              716                   Ict.               11                 117            Gripp.             8                86   Gripp., Can.   20   249   Pom., Gripp.         2   32   Austr., Gripp.   15   198   Pom.           35   695   Gripp.         0   2   ---   0   1   ---

Annual numbers of individual small mammal species, from ten species sampled, with positive result by MAT.

Antibodies to *Leptospira* spp. were detected in 276 animals by MAT (9.79% ± 0.56%). Samples were collected from 10 species with a preponderance of *A. agrarius*, *R. norvegicus*, and *M. musculus* (75.71%). Among the examined small mammals, the carriers of pathogenic *Leptospira* spp. were animals from natural habitats (*A. agrarius*, *Apodemus flavicollis*, *Sorex araneus*, *A. sylvaticus*, *Myodes glareolus*, *Microtus arvalis*, and *Dryomys nitedula*) as well as synanthropic small mammals (*R. norvegicus* and *M. musculus*). Generally, when a species of small mammal was well represented in the collections (\>50 animals), the prevalence of infected animals tended around 10--15%, with the exception of *M. musculus* where the prevalence was about half that level ([Table 4](#T4){ref-type="table"}). There was a significant difference in the proportion of positive animals by species (χ^2^ = 39.26; *p* \< 0.001). The "excess" of positive *A. agrarius* and the dearth of positive *M. musculus* accounted for more than 80% of the deviation from independence of infection among species. Despite this, evidence for infection in *multiple species* was common.

###### 

Summary of Prevalence Results for Serologic Studies of Rodents for 2005--2015

  *Species*                      Apodemus agrarius   Rattus norvegicus   Apodemus flavicollis   Sorex araneus   Apodemus sylvaticus   Microtus arvalis   Myodes glareolus   Mus musculus
  ------------------------------ ------------------- ------------------- ---------------------- --------------- --------------------- ------------------ ------------------ --------------
  Total no. of studied rodents   724                 716                 117                    86              249                   198                32                 695
  Positive test no.              104                 81                  11                     8               20                    15                 2                  35
  Percentage of positive tests   14.36 ± 1.3         11.31 ± 1.18        9.40 ± 2.7             9.30 ± 3.13     8.03 ± 1.72           7.58 ± 1.88        6.25 ± 4.28        5.04 ± 0.83

There is a statistically significant association (χ^2^ = 39.26; *p* \< 0.001) between small mammal species and the likelihood of positive Microscopic Agglutination Test results.

Most of the serogroups identified in small mammals included Icterohaemorrhagiae, Pomona, and Grippotyphosa of *Leptospira* spp. During the study period, changes in the dominant serogroups were observed among the small mammals, as much as was observed in humans. However, the changes in small mammal serogroups did not mirror the changes seen in humans across years. Thus, for the period from 2005 to 2009, the dominant serogroups in rodents were Icterohaemorrhagiae (44.6%) and Pomona (34.4%). From 2010 to 2012, Pomona became dominant (50.9% of positives). From 2013 to 2015, Grippotyphosa became the dominant serogroup (53.2% of all positives). Moreover, during this period, rarely encountered serogroups (Australis, Ballum, Bataviae, and Autumnalis) were identified in 17 cases (27.42%) ([Fig. 2b](#f2){ref-type="fig"}).

While serogroups Icterohaemorrhagiae, Hebdomadis, Pomona, Canicola, Grippotyphosa, Autumnalis, Ballum, and Tarassovi of *Leptospira* spp. were reported in humans cases and studied rodents, the prevalence differed between the two groups within years ([Fig. 2a, b](#f2){ref-type="fig"}). Thus, small mammals remain to be the main source of pathogenic *Leptospira* spp. for humans, but additional factor(s) are associated with the likelihood of transmission to the humans on a yearly basis.

Discussion {#s007}
==========

Leptospirosis is an infectious disease of global importance, which occurs both in urban regions of industrialized and developing countries, as well as in rural regions. Importation of leptospirosis is possible due to expanding international connections, tourism, and recreation (Bharti et al. [@B3], Pappas et al. [@B11]).

Nearly the entire territory of Ukraine is enzootic for leptospirosis. Since 2008, a decreasing morbidity trend has been reported. Overall, the national-level mean incidence was 1.02 per 100,000 population. However, the incidence generally declined from 2005 to 2015, from 1.44 per 100,000 population (674 cases) in 2007 to 0.68 per 100,000 population (310 cases) in 2011. During the same time, leptospirosis morbidity in European countries typically was lower than in Ukraine (Pappas et al. [@B11]).

Zakarpattia oblast shares borders with Romania, Hungary, Poland, and Slovakia in the West, and with Ivano-Frankivsk and L\'viv oblasts of Ukraine in the East. Zakarpattia is a territory with moderate continental climate, with sufficient and excessive moisture, moderately hot summers, and mild winters (Pop [@B12]). There are geographical, landscape, zoological, and parasitological conditions that influence various natural focal diseases, including leptospirosis. The human population density in the oblast is above the average for the country, and a large proportion of the population (63%) lives in rural areas. High leptospirosis incidence is often reported in regions with high proportions of surface fresh water (Wasiński et al. [@B17]). The river system in Zakarpattia is the densest in Ukraine (1.7 km/km^2^), which is influenced by high humidity and mountain relief. Increasing water levels in spring and early summer, and recurrent flooding are typical for Zakarpattia, which can have disastrous impacts (Markovych [@B8]). In 2010, for example, flooding caused by prolonged heavy rain in June--July inundated villages in lowland rayons of Zakarpattia. During this period, leptospirosis incidence peaked ([Table 2](#T2){ref-type="table"}).

Flooding is one of the aspects of climate change that may lead to increased morbidity of infectious diseases, including leptospirosis. Higher leptospirosis morbidity after floods also was reported in the Czech Republic, and in Poland after the floods in 1997--2002 (Desai et al. [@B5]; Wasiński et al. 2013). Although in temperate climatic zones, leptospires survive in the environment for a much shorter time than in tropical countries, increased floods may drive the reemergence of disease.

During the study period, 420 leptospirosis cases were recorded in the oblast, and the incidence was three times higher than the average incidence for Ukraine ([Table 2](#T2){ref-type="table"}). The case-fatality rate in the oblast also was elevated compared to national statistics ([Fig. 1](#f1){ref-type="fig"}). The predominant serogroups in humans were Icterohaemorrhagiae, Hebdomadis, and Grippotyphosa of *Leptospira* spp. with a shift in the predominant serogroups during the study ([Fig. 2a](#f2){ref-type="fig"}).

The most important natural sources of infection are various small rodent species. Studies conducted in Croatia showed that 7.0% to 29.9% of small rodents carried *Leptospira* (Majetić et al. [@B7]). In the Czech Republic, serological studies of 4634 samples from wild mammals found 12% positive, and of these, 99% had antibodies against serovars belonging to Grippotyphosa serogroup. This serogroup is maintained within various small rodent species in Europe, including common voles (*Microtus arvalis*), muskrat (*Ondatra zibethicus*), European hamster (*Cricetus cricetus*), wood mouse (*A. sylvaticus*), and the yellow-necked mouse (*A. flavicollis*) (Żmudzki et al. 2016).

Studies in Switzerland on the prevalence of *Leptospira* infections in urban populations of rodents showed, depending on the species, 10--20% positive results (Adler et al. [@B1]). In Germany, a study on *Rattus* from 16 urban regions revealed 19% of kidney samples contained DNA of *Leptospira* spp. (Mayer-Scholl et al. [@B9]). Serological surveys of rats trapped in Wrocław, Silesia (Poland), found antibodies to serovars Icterohaemorrhagiae, Canicola, Hebdomadis, and Sejroe (Wincewicz et al. [@B18]).

The Zakarpattia fauna contains ∼80 species of mammals and more than 45% of mammals are rodents. Small rodent populations have sharp seasonal increases and declines. In the spring, their number is not large; while population peaks in the autumn (Pop [@B12]). Among tested rodent species, *A. agrarius*, *R. norvegicus*, and *M. musculus* were most common (75.7% of all captures). Positive results were found both in the natural areas and among synanthropic rodents. During the study period, the predominant serogroups changed ([Fig. 2b](#f2){ref-type="fig"}). According to researchers, recurrent change of the dominant *Leptospira* serogroup has been recognized. For example, the predominant serogroups in cattle from the Leningrad oblast of Russia during 1968--2006 and changes of *Leptospira* serogroup etiological structure in cattle and pigs herds have been described in Khabarovkyi Krai in Russia (Sidelnikov [@B13], Badra [@B2]). The factors that drive these changes remain to be further studied. However, the change of infection pattern in the small community of mammals may alter risk of different serogroups on neighboring human population.

Conclusions {#s008}
===========

The numbers of patients with leptospirosis in Zakarpattia oblast of Ukraine decreased more than fivefold during the past decade. *Leptospira* infections in small mammals were common across *multiple species* ranging from 5% to 14% in eight species with sufficiently sampled individuals. Antibodies of serogroups of *Leptospira* spp. detected in patients matched those of studied rodents, but differed in proportions of occurrence. This suggests that, while the small mammals were likely sources of infection, the contact with various species may impact the exposure in this endemic region. Thus, changes in the patterns of infection in the small mammal community might drive changes in the exposure risk to different serogroups in adjacent human populations.
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